Recombinant AAV-mediated HSVtk Gene Transfer with Direct Intratumoral Injections and Tet-On Regulation for Implanted Human Breast Cancer

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2006 Mar 17

PMID 16539746

Citations 15

Authors

Zi-Bo Li

Zhao-Jun Zeng

Qian Chen

Sai-Qun Luo

Wei-Xin Hu

Affiliations

Soon will be listed here.

Abstract

Background: HSVtk/ganciclovir (GCV) gene therapy has been extensively studied in tumors and relies largely on the gene expression of HSVtk. Most studies, however, have failed to demonstrate any significant benefit of a controlled gene expression strategy in cancer treatment. The Tet-On system is commonly used to regulate gene expression following Dox induction. We have evaluated the antitumor effect of HSVtk/ganciclovir gene therapy under Tet-On regulation by means of adeno-associated virus-2 (AAV-2)-mediated HSVtk gene transfer with direct intratumoral injections in mice bearing breast cancer tumors.

Methods: Recombinant adeno-associated virus-2 (rAAV) was constructed and transduced into MCF-7 cell line. GCV treatment to the rAAV infected MCF-7 cells was performed by MTT assay under the doxycycline (Dox) induction or without Dox induction at a vp (viral particle) number of > or =10(4)/cell. The virus was administered intratumorally to nude mice that had also received GCV intraperitoneally. The antitumor effects were evaluated by measuring tumor regression and histological analysis.

Results: We have demonstrated that GCV treatment to the infected MCF-7 cells under the Dox induction was of more inhibited effects than those without Dox induction at > or =10(4) vp/cell. In ex vivo experiments, tumor growth of BALB/C nude mice breast cancer was retarded after rAAV-2/HSVtk/Tet-On was injected into the tumors under the Dox induction. Infiltrating cells were also observed in tumors after Dox induction followed by GCV treatment and cells were profoundly damaged. The expression of HSVtk gene in MCF-7 cells and BALB/C nude mice tumors was up-regulated by Tet-On under Dox induction with reverse transcription-PCR (RT-PCR) analysis.

Conclusion: The antitumor effect of rAAV-mediated HSVtk/GCV gene therapy under the Dox induction with direct intratumoral injections may be a useful treatment for breast cancer and other solid tumors.

Citing Articles

AAV-mediated combination gene therapy of inducible Caspase 9 and miR-199a-5p is therapeutic in hepatocellular carcinoma.

Pathak S, Singh V, Kumar G N, Jayandharan G Cancer Gene Ther. 2024; 31(12):1796-1803.

PMID: 39385010 DOI: 10.1038/s41417-024-00844-x.

Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer.

Pathak S, Singh V, Kumar N, Jayandharan G Mol Ther Methods Clin Dev. 2023; 31:101166.

PMID: 38149057 PMC: 10750187. DOI: 10.1016/j.omtm.2023.101166.

AAV genome modification for efficient AAV production.

Asaad W, Volos P, Maksimov D, Khavina E, Deviatkin A, Mityaeva O Heliyon. 2023; 9(4):e15071.

PMID: 37095911 PMC: 10121408. DOI: 10.1016/j.heliyon.2023.e15071.

Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy.

Bower J, Song L, Bastola P, Hirsch M Viruses. 2021; 13(7).

PMID: 34201599 PMC: 8309980. DOI: 10.3390/v13071205.

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.

Hacker U, Bentler M, Kaniowska D, Morgan M, Buning H Cancers (Basel). 2020; 12(7).

PMID: 32674264 PMC: 7409174. DOI: 10.3390/cancers12071889.

References

Sevignani C, Calin G, Cesari R, Sarti M, Ishii H, Yendamuri S . Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res. 2003; 63(6):1183-7. View

Hu W, Zeng Z, Luo S, Chen Q . Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On. Chin Med J (Engl). 2004; 117(3):434-9. View

Beltinger C, Fulda S, Kammertoens T, Uckert W, Debatin K . Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis. Cancer Res. 2000; 60(12):3212-7. View

Zabala M, Wang L, Hernandez-Alcoceba R, Hillen W, Qian C, Prieto J . Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res. 2004; 64(8):2799-804. DOI: 10.1158/0008-5472.can-03-3061. View

Qiao J, Doubrovin M, Sauter B, Huang Y, Guo Z, Balatoni J . Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther. 2002; 9(3):168-75. DOI: 10.1038/sj.gt.3301618. View

Hillman G, Slos P, Wang Y, Wright J, Layer A, De Meyer M . Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Ther. 2003; 11(1):61-72. DOI: 10.1038/sj.cgt.7700656. View

Aurisicchio L, Bujard H, Hillen W, Cortese R, Ciliberto G, La Monica N . Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. Gene Ther. 2002; 8(24):1817-25. PMC: 7091917. DOI: 10.1038/sj.gt.3301596. View

Chtarto A, Bender H, Hanemann C, Kemp T, Lehtonen E, Levivier M . Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Ther. 2003; 10(1):84-94. DOI: 10.1038/sj.gt.3301838. View

Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H . Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther. 2004; 9(4):587-95. DOI: 10.1016/j.ymthe.2003.12.009. View

10.

Hawkins R . Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene Ther. 1998; 5(1):76-84. DOI: 10.1038/sj.gt.3300557. View

11.

Lin T, Zhang L, Davis J, Gu J, Nishizaki M, Ji L . Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. Mol Ther. 2003; 8(3):441-8. DOI: 10.1016/s1525-0016(03)00203-x. View

12.

Maeda T, O-Wang J, Matsubara H, Asano T, Ochiai T, Sakiyama S . A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir. Cancer Gene Ther. 2002; 8(11):890-6. DOI: 10.1038/sj.cgt.7700389. View

13.

Goto T, Nishi T, Kobayashi O, Tamura T, Dev S, Takeshima H . Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo. Mol Ther. 2004; 10(5):929-37. DOI: 10.1016/j.ymthe.2004.07.028. View

14.

Fitzsimons H, McKenzie J, During M . Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther. 2002; 8(22):1675-81. DOI: 10.1038/sj.gt.3301582. View

15.

Sobotkova E, Duskova M, Smahel M, Holan V, Janouskova O, Vonka V . Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells. Oncol Rep. 2004; 12(4):877-83. View

16.

Stribbling S, Friedlos F, Martin J, Davies L, Spooner R, Marais R . Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect. Hum Gene Ther. 2000; 11(2):285-92. DOI: 10.1089/10430340050016021. View

17.

Enger P, Thorsen F, Lonning P, Bjerkvig R, Hoover F . Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors. Hum Gene Ther. 2002; 13(9):1115-25. DOI: 10.1089/104303402753812511. View

18.

Shockett P, Zhou S, Hong X, Schatz D . Partial reconstitution of V(D)J rearrangement and lymphocyte development in RAG-deficient mice expressing inducible, tetracycline-regulated RAG transgenes. Mol Immunol. 2003; 40(11):813-29. DOI: 10.1016/j.molimm.2003.09.009. View

19.

Wang Y, Hu J, Krol A, Li Y, Li C, Yuan F . Systemic dissemination of viral vectors during intratumoral injection. Mol Cancer Ther. 2003; 2(11):1233-42. View

20.

Grimm D, Kleinschmidt J . Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use. Hum Gene Ther. 1999; 10(15):2445-50. DOI: 10.1089/10430349950016799. View